Ph.D. in Biology or related discipline with 4+ years of industry experience
Experience with biomarker endpoints in early-stage clinical development
Specific expertise in CNS, ophthalmic, and inflammatory diseases
Background in immunology is highly desired
Strong collaboration skills with cross-functional teams
Responsibilities
Develop translational biomarker strategies for clinical development and commercialization
Partner with Research to identify and characterize novel biomarker endpoints
Create and validate biomarker methods for clinical applications
Implement clinical biomarkers in trials
Collaborate with Biostats and Modeling to drive biomarker decision-making
Report biomarker results and guide next steps with cross-functional teams
Oversee CRO partners to ensure effective execution of biomarker projects
Support Business Development with diligence efforts as needed
Benefits
Opportunity to work on cutting-edge cellular therapies
Highly visible role with internal and external stakeholders
Collaboration with experts across multiple therapeutic areas
Engagement in impactful clinical development programs
Location in Cambridge, Massachusetts, a hub for biotech innovation
Full Job Description
Description of Position:
It continues to be an exciting time for BlueRock Therapeutics as the company advances cutting edge cellular therapies to positively impact patients' lives across multiple disease areas.
The Associate Director, TMND, will be expected to take on a highly visible role with internal and external stakeholders through the management of biomarker endpoints, including digital health readouts, leveraged in BlueRock's clinical development programs. The Associate Director of Translational Medicine will leverage their expertise across multiple therapeutic areas including neurology and ophthalmology to advance the company's development pipeline by working closely with program leads and other subject matter experts. The position will be based in Cambridge, Massachusetts.
Responsibilities:
As a critical member of the team, the Associate Director of TMND will leverage their expertise to:
Develop translational biomarker strategies designed to support clinical development plans, the regulatory path, and product commercialization.
Partner with Research to discover and characterize novel biomarker endpoints in preclinical studies.
Develop biomarker methods and analytically validate biomarkers for clinical use.
Support the implementation of clinical biomarkers in clinical trials.
Partner with Biostats and Modeling and Simulations to ensure biomarker-driven decision-making across all phases of drug development.
Partner with Clinical Development, TMND, and other cross-functional teams to report biomarker results and drive interpretation and next steps.
Oversee CRO vendor/partners ensuring that they optimally execute clinical and preclinical biomarker projects in the US, Europe and other key geographic regions of interest.
Provide support for the Business Development organizations as needed on diligence efforts.
Minimum Requirements:
Ph.D. in Biology or related discipline with at least 4 years of industry experience.
Specific experience with biomarker endpoints for early-stage clinical development in CNS, ophthalmic and inflammatory diseases is desired.
Background in immunology highly desired.
The estimated compensation range for this position is $ 181,000.00 - $ 192,060.00 per year.
About BlueRock Therapeutics
BlueRock Therapeutics is a biotechnology company that develops engineered cell therapies to cure diseases. The company's platform is based on induced pluripotent stem cells (iPSCs) and gene editing technologies. BlueRock Therapeutics is focused on developing therapies for diseases of the central nervous system, cardiovascular system, and immunology. The company was founded in 2016 and is headquartered in Cambridge, Massachusetts.